Should we unstress SARS-CoV-2 infected cells?

Cytokine Growth Factor Rev. 2020 Aug:54:3-5. doi: 10.1016/j.cytogfr.2020.06.011. Epub 2020 Jun 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Betacoronavirus / drug effects
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / mortality
  • Coronavirus Infections / pathology*
  • Cytokine Release Syndrome / drug therapy
  • Humans
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / mortality
  • Pneumonia, Viral / pathology*
  • Prognosis
  • Risk Factors
  • SARS-CoV-2
  • Stress, Physiological / physiology*

Substances

  • Anti-Inflammatory Agents